We are currently facing a worldwide epidemic of syphilis. Clinical manifestations that are rarely seen have been encountered, leading the dermatologist to confront unusual clinical conditions in daily practice. Erythema multiforme triggered by syphilis is very rare and is also seldom reported in the literature. We report a case of secondary syphilis in an HIV-positive patient, whose clinical, pathologic and serologic features were consistent with the diagnosis of erythema multiforme triggered by syphilis.
A 29-year-old man was admitted to Emilio Ribas Infectious Diseases Institute (São Paulo, Brazil) with mucocutaneous lesions associated with pruritus for 14 days. The patient reported being diagnosed with HIV infection at a general clinic one week after the onset of the skin lesions, but had not yet begun antiretroviral therapy (ART). He was examined by our team at the hospital, where no other comorbidity besides HIV was reported. Physical examination demonstrated that the patient was in good general condition, afebrile, with a dermatosis characterized by erythematous macules and plaques disseminated over his body, including palmoplantar regions, lips, oral and genital mucosae. Some lesions were painful and pruritic and presented a small depressed central area, while others were eroded. No bullous lesions were observed (Figure 1 ). The patient had used diclofenac only after the onset of the lesions, and despite extensive questioning about the additional use of medicines he denied any prior drug use that could have triggered the lesions.
Results from laboratory tests were as following: VDRL 1/1024; FTA-Abs positive; HIV viral load 607,485 copies/mL (log 5.78); CD4þ T cells 311 cells/ mm 3 ; additional viral tests are shown in Table 1 . A diagnosis of malignant syphilis was proposed based on the clinical presentation and serological tests, with a second hypothesis of erythema multiforme (EM). The patient received 2,400,000 IU intramuscular benzathine penicillin, and a skin biopsy was performed. The patient was advised to return in seven days for reevaluation and further penicillin treatment. The skin biopsy was consistent with the diagnosis of EM (Figure 2 ). Immunohistochemical (IHC) analysis with a specific anti-Treponema pallidum polyclonal antibody was negative. There was a significant improvement of the symptoms at the first re-evaluation of the patient (Figure 3) .
Despite the improvement of the lesions, prednisone 1 mg/kg/day and hydroxyzine 100 mg/day for five days were prescribed, and a second dose of benzathine penicillin was administered, totaling 4,800,000 IU. At three weeks he received the last dose of benzathine penicillin, totaling 7,200,000 IU, at which time he presented only residual hyperchromic macules without scars ( Figure  4 ). During the 21-day follow-up, we did not prescribe ART to the patient, to avoid confusion with any changes in the lesions. The patient was referred to the primary healthcare unit after his symptoms improved to initiate ART.
Discussion
We are currently facing a worldwide epidemic of syphilis. Clinical manifestations that are rarely seen have been encountered, leading clinicians to confront unusual clinical conditions in daily practice, 1 such as secondary syphilis with EM-like lesions. Syphilisassociated EM is an atypical event rarely reported in the literature, and clinicians tend to ignore linking EM to this infection.
2,3
Syphilis in HIV-infected individuals can present different manifestations. [4] [5] [6] A rare form of secondary syphilis called early malignant syphilis (EMS) has been reported in HIV-infected patients, where the CD4þ/CD8þ imbalance correlates to the severity of the lesions. 7, 8 The diagnostic criteria for malignant syphilis are clinical and histopathological findings, high VDRL titers (or equivalent test), presence of intense and severe Jarisch-Herxheimer reaction, rapid resolution of the lesions with the appropriate therapy, and vascular alterations such as vasculitis or vascular occlusion, which coincide with the areas of necrosis and ulceration. 4, 6, 9, 10 EM is an acute immune-mediated hypersensitivity reaction. It is self-limited with dissemination of variable intensity, compromising skin and/or mucosae. Therefore, it is classified according to the extent of the lesions. The diagnosis is based on the patient's clinical history and the correlation with the morphological aspects of the lesions. 11 About 90% of the cases are triggered by herpes simplex virus (HSV) infection. 11 Other associated factors are immunological disorders and medications, including sulfonamides, non-hormonal anti-inflammatory drugs, penicillin, and anticonvulsants.
11
Skin biopsy did not favor the diagnosis of EMS. Viral infection-induced ballooning of cells was not observed. The increase in the number of lymphocytes, the presence of superficial perivascular and lichenoid infiltrates with extensive keratinocyte necrosis, and the negative IHC result for treponema suggest that the lesions were triggered by an immune-mediated response, as observed in EM, and not by the direct action of the bacteria on the lesions, as observed in secondary syphilis with EM-like lesions. 3, 9 It is not common to find treponema in biopsies from EMS lesions in HIVinfected patients. Transient viremia of cytomegalovirus (CMV) or HSV may cause EM and can be associated with HIV-infection, but the PCR results for these agents were negative as shown in Table 1 , supporting the diagnosis of EM due to syphilis. ART can trigger diverse adverse effects, from a discrete maculopapular reaction to toxic epidermal necrolysis, within the first 10 weeks of treatment. 2 Our patient had not taken any ART and used diclofenac only after the onset of the skin lesions.
In this report, the hypothesis of EMS was ruled out by the progression of the skin lesions after the antibiotic treatment, rapid resolution of lesions, the absence of Jarisch-Herxheimer (JH) reaction without corticosteroid use at the first week of treatment and skin biopsy. EM diagnosis is supported by the clinical observation of an abrupt onset of disseminated mucocutaneous lesions, corresponding to atypical 'target lesions', and case reports of patients with target lesions caused by treponemal infection have shown the presence of bacteria in the IHC. 2, 3, 8, [11] [12] [13] [14] There are rare reports of secondary syphilis presenting with EM-like lesions, but no case of reactional EM due to syphilitic infection. 3 We report a case of EM in which other possibilities of drug or infectious causes were excluded, indicating that syphilis was likely to have caused the lesions. The clinical evolution with improvement of the lesions after treatment for syphilis supports this possibility.
